Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells

[1]  Bernard Ducommun,et al.  The when and wheres of CDC25 phosphatases. , 2006, Current opinion in cell biology.

[2]  Mitsuo Tachibana,et al.  Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis , 2005, Clinical Cancer Research.

[3]  M. Ittmann,et al.  Increased Expression and Activity of CDC25C Phosphatase and an Alternatively Spliced Variant in Prostate Cancer , 2005, Clinical Cancer Research.

[4]  J. Dekker,et al.  Infection with Helicobacter pylori Affects All Major Secretory Cell Populations in the Human Antrum , 2005, Digestive Diseases and Sciences.

[5]  E. Bruyneel,et al.  The cancer chemopreventive agent resveratrol induces tensin, a cell–matrix adhesion protein with signaling and antitumor activities , 2005, Oncogene.

[6]  A. Lindqvist,et al.  Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import. , 2005, Experimental cell research.

[7]  S. Cohen,et al.  Connecting proliferation and apoptosis in development and disease , 2004, Nature Reviews Molecular Cell Biology.

[8]  B. Sayan,et al.  Methods in molecular medicine , 2004, Cell Death and Differentiation.

[9]  E. Bruyneel,et al.  Trefoil factor family (TFF) peptides and cancer progression , 2004, Peptides.

[10]  G. Enders,et al.  Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells , 2004, Oncogene.

[11]  Xinbin Chen,et al.  MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53* , 2004, Journal of Biological Chemistry.

[12]  J. Bartek,et al.  Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines , 2003, Oncogene.

[13]  L. Donehower,et al.  Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis , 2003, Oncogene.

[14]  D. Taupin,et al.  Trefoil factors: initiators of mucosal healing , 2003, Nature Reviews Molecular Cell Biology.

[15]  M. Mareel,et al.  Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells , 2003, Oncogene.

[16]  A. Flahault,et al.  Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression , 2003, Virchows Archiv.

[17]  M. Mareel,et al.  Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signaling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  L. Thim,et al.  The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis , 2002, The Journal of cell biology.

[19]  D. Kershenobich,et al.  TreFoil Factor 1 (TFF1/pS2) Deficiency Activates the Unfolded Protein Response , 2002, Molecular medicine.

[20]  M. Mareel,et al.  Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase‐ and thromboxane A2 receptor‐dependent signaling pathways , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  E. Campo,et al.  Differential Expression of cdc25 Cell-Cycle–Activating Phosphatases in Human Colorectal Carcinoma , 2001, Laboratory Investigation.

[22]  M. Mareel,et al.  Induction of scattering and cellular invasion by trefoil peptides in src‐ and RhoA‐transformed kidney and colonic epithelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Loda,et al.  Role of the Cdc25A phosphatase in human breast cancer. , 2000, The Journal of clinical investigation.

[24]  D. Taupin,et al.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[26]  L. Thim,et al.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. , 1996, Gastroenterology.

[27]  M. Loda,et al.  CDC25 phosphatases as potential human oncogenes. , 1995, Science.

[28]  L. Thim,et al.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. , 1995, Gastroenterology.

[29]  Frans,et al.  Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.

[30]  R. Lathe,et al.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. , 1988, Science.

[31]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[32]  Jing Lin,et al.  Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells , 2005, Clinical & Experimental Metastasis.

[33]  C. Cerni,et al.  Subcellular localisation of Cdc25A determines cell fate , 2004, Cell Death and Differentiation.

[34]  C. Tomasetto,et al.  pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.

[35]  M. Mareel,et al.  Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. , 1997, British Journal of Cancer.